Viatris (VTRS) Earnings Date & Reports

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

VTRS is expected to report earnings to rise 2.85% to 60 cents per share on August 10

Q2'26

Est.

$0.61

Q1'26

Beat

by $0.08

Q4'25

Beat

by $0.03

Q3'25

Beat

by $0.05

Q2'25

Beat

by $0.07

The last earnings report on May 07 showed earnings per share of 58 cents, beating the estimate of 50 cents. With 8.81M shares outstanding, the current market capitalization sits at 18.33B.

View a ticker or compare two or three

Compare

VTRS

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for VTRS